-
1
-
-
15644382459
-
Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors
-
Northern New England Cardiovascular Disease Study Group
-
Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 1998; 133: 442-7.
-
(1998)
Arch. Surg.
, vol.133
, pp. 442-447
-
-
Dacey, L.J.1
Munoz, J.J.2
Baribeau, Y.R.3
-
2
-
-
0028946605
-
Resternotomy for bleeding after cardiac operation: A marker for increase morbidity and mortality
-
Unsworth-White MJ, Herriot A, Valencia O. Resternotomy for bleeding after cardiac operation: a marker for increase morbidity and mortality. Ann Thorac Surg 1995; 59: 664-7.
-
(1995)
Ann. Thorac. Surg.
, vol.59
, pp. 664-667
-
-
Unsworth-White, M.J.1
Herriot, A.2
Valencia, O.3
-
3
-
-
0031960143
-
Management of bleeding complications in redo cardiac operations
-
Smith CR. Management of bleeding complications in redo cardiac operations. Ann Thorac Surg 1998; 65: 2-8.
-
(1998)
Ann. Thorac. Surg.
, vol.65
, pp. 2-8
-
-
Smith, C.R.1
-
5
-
-
0026793447
-
Early activation of hemostasis during cardiopulmonary bypass: Evidence for thrombin mediated hyperfibrinolysis
-
Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992; 68: 250-2.
-
(1992)
Thromb. Haemost.
, vol.68
, pp. 250-252
-
-
Teufelsbauer, H.1
Proidl, S.2
Havel, M.3
-
6
-
-
0025230919
-
Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding
-
Gram J, Janetzko T, Jespersen J, et al. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost 1990; 63: 241-5.
-
(1990)
Thromb. Haemost.
, vol.63
, pp. 241-245
-
-
Gram, J.1
Janetzko, T.2
Jespersen, J.3
-
7
-
-
0019180607
-
Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transident platelet dysfunktion associated with selective alpha-granule release
-
Harker LA, Malpass TW, Branson HE, et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transident platelet dysfunktion associated with selective alpha-granule release. Blood 1980; 56: 824-34.
-
(1980)
Blood
, vol.56
, pp. 824-834
-
-
Harker, L.A.1
Malpass, T.W.2
Branson, H.E.3
-
8
-
-
0023058864
-
Bleeding after cardiopulmonary bypass
-
Harker LA. Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314: 446-8.
-
(1986)
N. Engl. J. Med.
, vol.314
, pp. 446-448
-
-
Harker, L.A.1
-
9
-
-
0024509887
-
Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (trasylol)
-
Bidstrup BP, Royston D, Sapstord RN, et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (trasylol). J Thorac Cardiovasc Surg 1989; 97: 364-72.
-
(1989)
J. Thorac. Cardiovasc. Surg.
, vol.97
, pp. 364-372
-
-
Bidstrup, B.P.1
Royston, D.2
Sapstord, R.N.3
-
10
-
-
0028079871
-
Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding
-
Fremes SE, Wong BI, Lee E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994; 58: 1580-8.
-
(1994)
Ann. Thorac. Surg.
, vol.58
, pp. 1580-1588
-
-
Fremes, S.E.1
Wong, B.I.2
Lee, E.3
-
11
-
-
0031415922
-
Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
-
for The International Study of Peri-operative Transfusion (ISPOT) Investigators
-
Laupacis A, Fergusson D, for The International Study of Peri-operative Transfusion (ISPOT) Investigators. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 1997; 85: 1258-67.
-
(1997)
Anesth. Analg.
, vol.85
, pp. 1258-1267
-
-
Laupacis, A.1
Fergusson, D.2
-
12
-
-
0033524140
-
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
-
Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354: 1940-7.
-
(1999)
Lancet
, vol.354
, pp. 1940-1947
-
-
Levi, M.1
Cromheecke, M.E.2
de Jonge, E.3
-
13
-
-
0025992843
-
Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary Bypass
-
Blauhaupt B, Gross C, Necek S, et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary Bypass. J Thorac Cardiovasc Surg 1991; 101: 958-67.
-
(1991)
J. Thorac. Cardiovasc. Surg.
, vol.101
, pp. 958-967
-
-
Blauhaupt, B.1
Gross, C.2
Necek, S.3
-
14
-
-
0027216882
-
Mechanism of the preserving effect of aprotinin on platelet function and its use in cardic surgery
-
Huang H, Ding W, Su W, et al. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardic surgery. J Thorac Cardiovasc Surg 1993; 106: 11-8.
-
(1993)
J. Thorac. Cardiovasc. Surg.
, vol.106
, pp. 11-18
-
-
Huang, H.1
Ding, W.2
Su, W.3
-
15
-
-
0028311431
-
Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss: Results of a double-blind randomized clinical trial
-
Kallis P, Tooze JA, Talbot S, et al. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss: results of a double-blind randomized clinical trial. Eur J Cardiothorac Surg 1994; 8: 315-23.
-
(1994)
Eur. J. Cardiothorac. Surg.
, vol.8
, pp. 315-323
-
-
Kallis, P.1
Tooze, J.A.2
Talbot, S.3
-
16
-
-
0028965954
-
One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery- effect of Aprotinin
-
Mannucci L, Gerometta PS, Mussoni L, et al. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery- effect of Aprotinin. Thromb Haemost 1995; 73: 356-61.
-
(1995)
Thromb. Haemost.
, vol.73
, pp. 356-361
-
-
Mannucci, L.1
Gerometta, P.S.2
Mussoni, L.3
-
17
-
-
0029195783
-
Suppressed fibrinolysis after administration of low-dose aprotinin: Reduced level of plasmin-alpha-2-plasmin inhibitor complexes and postoperative blood loss
-
Mastroroberto P, Chello M, Zofrea S, et al. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha-2-plasmin inhibitor complexes and postoperative blood loss. Eur J Cardio-Thorac Surg 1995; 9: 143-5.
-
(1995)
Eur. J. Cardio-Thorac. Surg.
, vol.9
, pp. 143-145
-
-
Mastroroberto, P.1
Chello, M.2
Zofrea, S.3
-
18
-
-
0025995998
-
The effects of aprotinin on hemostatic function during cardiac surgery
-
Marx G, Pokar H, Reuter H, et al. The effects of aprotinin on hemostatic function during cardiac surgery. J Cardiothorac Vasc Anesth 1991; 5: 467-74.
-
(1991)
J. Cardiothorac. Vasc. Anesth.
, vol.5
, pp. 467-474
-
-
Marx, G.1
Pokar, H.2
Reuter, H.3
-
19
-
-
0034848241
-
Low-dose postoperative aprotinin reduces mediastional drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: A prospective randomized, double-blind, placebo-controlled trial
-
Alvarez JM, Jackson LR, Chatwin C, et al. Low-dose postoperative aprotinin reduces mediastional drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective randomized, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg 2001; 122: 457-63.
-
(2001)
J. Thorac. Cardiovasc. Surg.
, vol.122
, pp. 457-463
-
-
Alvarez, J.M.1
Jackson, L.R.2
Chatwin, C.3
-
20
-
-
0029798742
-
Aprotinin in primary valve replacement and reconstuction: A multicenter, double-blind, placebo-controlld trial
-
D'Ambra, MN, Akins CW, Blackstone EH, et al. Aprotinin in primary valve replacement and reconstuction: a multicenter, double-blind, placebo-controlld trial. J Thorac Cardiovasc Surg 1996; 112: 1081-9.
-
(1996)
J. Thorac. Cardiovasc. Surg.
, vol.112
, pp. 1081-1089
-
-
D'Ambra, M.N.1
Akins, C.W.2
Blackstone, E.H.3
-
21
-
-
0027818956
-
Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients
-
Hardy JF, Desroches J, Belisle S, et al. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients. Can J Anaesth 1993; 40: 625-31.
-
(1993)
Can. J. Anaesth.
, vol.40
, pp. 625-631
-
-
Hardy, J.F.1
Desroches, J.2
Belisle, S.3
-
22
-
-
10544236908
-
Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens
-
Lemmer JH Jr, Dilling EW, Morton JR, et al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. Ann Thorac Surg 1996; 62: 1659-68.
-
(1996)
Ann. Thorac. Surg.
, vol.62
, pp. 1659-1668
-
-
Lemmer Jr., J.H.1
Dilling, E.W.2
Morton, J.R.3
-
24
-
-
0029729898
-
Aprotinin: Safe and effective only with the full-dose regimen
-
(editoral)
-
Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen (editoral). Ann Thorac Surg 1996; 62: 1575-7.
-
(1996)
Ann. Thorac. Surg.
, vol.62
, pp. 1575-1577
-
-
Smith, P.K.1
Muhlbaier, L.H.2
-
26
-
-
0027415362
-
Topical use of aprotinin in open heart operation
-
Tatar H, Cicek S, Demirkilic U, et al. Topical use of aprotinin in open heart operation. Ann Thorac Surg 1993; 55: 659-61.
-
(1993)
Ann. Thorac. Surg.
, vol.55
, pp. 659-661
-
-
Tatar, H.1
Cicek, S.2
Demirkilic, U.3
-
27
-
-
4544281222
-
High-dose aprotinin therapy: A review of the first five years' experience
-
Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth 1991; 5: 467-74.
-
(1991)
J. Cardiothorac. Vasc. Anesth.
, vol.5
, pp. 467-474
-
-
Royston, D.1
-
28
-
-
0027435353
-
Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass
-
Tabuchi N, de Haan J, Boonstra PW, et al. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 828-33.
-
(1993)
J. Thorac. Cardiovasc. Surg.
, vol.106
, pp. 828-833
-
-
Tabuchi, N.1
de Haan, J.2
Boonstra, P.W.3
-
29
-
-
0028840040
-
Topical effect of aprotinin on surgical wound in cardiac surgery
-
(letter to the editor, reply to the editor)
-
Tabuchi N, de Haan J, van Oeveren W. Topical effect of aprotinin on surgical wound in cardiac surgery (letter to the editor, reply to the editor). J Thorac Cardiovasc Surg 1995; 109: 399-400.
-
(1995)
J. Thorac. Cardiovasc. Surg.
, vol.109
, pp. 399-400
-
-
Tabuchi, N.1
de Haan, J.2
van Oeveren, W.3
-
30
-
-
0027716817
-
Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during reperfusion of shed blood after cardiopulmonary bypass
-
de Hann J, Schönberger JPAM, Haan J, et al. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during reperfusion of shed blood after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1017-23.
-
(1993)
J. Thorac. Cardiovasc. Surg.
, vol.106
, pp. 1017-1023
-
-
de Hann, J.1
Schönberger, J.P.A.M.2
Haan, J.3
-
31
-
-
0033866107
-
Aprotinin adninistration in the pericardial cavity does not prevent platelet activation
-
Maquelin KN, Nieuwland R, Lentjes EGWM, et al. Aprotinin adninistration in the pericardial cavity does not prevent platelet activation. J Thorac Cardiovasc Surg. 2000; 120: 552-7.
-
(2000)
J. Thorac. Cardiovasc. Surg.
, vol.120
, pp. 552-557
-
-
Maquelin, K.N.1
Nieuwland, R.2
Lentjes, E.G.W.M.3
-
32
-
-
4544271347
-
-
Gerinnungsanalysen: Interpretation, Schnellorientierung, Therapiekontrollen. Stuttgart, New York, Thieme
-
Barthels M, Poliwoda H. Gerinnungsanalysen: Interpretation, Schnellorientierung, Therapiekontrollen. Stuttgart, New York, Thieme; 1993.
-
(1993)
-
-
Barthels, M.1
Poliwoda, H.2
-
33
-
-
0029049246
-
Topical use of aprotinin in cardiac surgery (letter to the editor)
-
Cicek S, Tatar H, Demirkilic U, et al. Topical use of aprotinin in cardiac surgery (letter to the editor). J Thorac Cardiovasc Surg 1995; 110: 568-9.
-
(1995)
J. Thorac. Cardiovasc. Surg.
, vol.110
, pp. 568-569
-
-
Cicek, S.1
Tatar, H.2
Demirkilic, U.3
|